Mr. Speaker, I thank my colleague from Florida for yielding time, and I yield myself such time as I may consume. You know, he mentioned that we have no problem on one day voting for tax decreases and then the next day voting against…

I yield myself such time as I may consume. I know our colleagues again continue to want to rewrite history, but it's just not something we're going to let you do. Our economy was doing great until you all took over the Congress in January…

Mr. Speaker, I ask unanimous consent to reclaim my time. The SPEAKER pro tempore. Is there objection to the request of the gentlewoman from North Carolina? There was no objection.

I have certainly had many prayers going out to the family members of the 11 individuals that were killed on the rig, and certainly, we are all so concerned about the devastation that has wreaked havoc in the whole Gulf area having to do…

One challenge that many of the witnesses today spoke of is the need to incentivize the device and drug/biotech industry to develop therapeutics for rare, pediatric diseases.

This committee has shown great leadership on this issue in the past, and I am committed to seeing it continue to ensure progress continues for children with rare and neglected diseases.

How many of these are rare diseases? Is there any effort underway to expand the number of diseases we screen for? Why or why not?

If the treatment is a drug that has not been approved by the Food and Drug Administration or has not been specifically approved for a child's particular disease, then insurance companies typically will not cover it because the treatment is…

I, too, believe that helping every American child reach their full potential is one of the most important things that we, as public officials, can hope to do.

That is why Senator Specter and I introduced Nino's Act, S. 406, which will allow children to transition out of successful treatment in NIH studies without a gap in treatment.

Mr. Speaker, one business organization after another has made it clear: The policies of this President and this Democrat- controlled Congress are creating uncertainty all throughout the private sector. Whether it's the Chamber of Commerce…

Madam Speaker, there is an interesting new development on the ObamaCare front. Remember the penalties on families that do not purchase health insurance, the ones that will top $2,000 for many families? Remember what President Obama said…

I believe the committee has to be robust in our oversight.

I think that you bring to this position a rich experience that many have covered, as well as yourself, that benefits one's ability to be successful.

It disturbs me as we promote Unmanned Aerial Vehicles on TV, and we do it with the full knowledge of knowing that we give away something every time we do it.

I thank the Senator. If I may, I have one additional question. When considering whether an entity maintains a substantial position in swaps, should the CFTC and the SEC look at the aggregate positions of funds managed by asset managers or…

Mr. President, today I am proud to introduce the Culture of Safety Hospital Accountability Act. This bill will test alternatives to the current, inflexible system to ensure that hospitals are meeting the highest health and safety standards…

Madam President, I rise today to discuss the conference agreement on financial services regulatory reform and specifically an issue in section 619 of title VI, known as the Volcker rule. The section's limitations on financial organizations…